News

Safety Shot, Inc. Completes Strategic Changes to Propel Growth

Safety Shot, Inc. Completes Strategic Changes to Propel Growth

Safety Shot, Inc. Takes Significant Steps Towards Future Growth

Safety Shot, Inc. (NASDAQ: SHOT), a leader in the wellness and dietary supplements sector, has made a pivotal decision regarding its financial strategy by terminating its at-the-market (ATM) equity offering program. This move is a clear indicator of the company’s robust financial health and its dedication to enhancing shareholder value.

CEO's Insights on Financial Strategy

Jarrett Boon, the CEO of Safety Shot, expressed confidence in the decision to halt the ATM program, stating, "This strategic step demonstrates our commitment to maximizing shareholder value while ensuring the company remains on a solid growth path." The termination of this program reduces the potential for further equity dilution, which is a positive sign for investors concerned about share values.

Growth Through Strategic Partnerships

In 2024, Safety Shot has secured numerous key distribution agreements with prominent retailers, setting the stage for upcoming success. Here are some highlights of these strategic partnerships:

Major Retail Partnerships

  • 7-Eleven: Safety Shot products will now be available in 300 stores across a major metropolitan area.
  • Casey’s General Stores: The brand is set to distribute Yerbae, an exciting acquisition, in over 300 locations.
  • King Soopers: Expansion continues with the distribution of Yerbae in various stores throughout Colorado.
  • Two Major Grocers: Sure Shot will be offered in two significant grocery chains with a combined total of over 2,400 stores nationwide.

These strategic collaborations and the acquisition of Yerbae Brands Corp. represent not only safety Shot’s commitment to growth but also their focus on penetrating the market effectively in 2025 and beyond. The company aims to amplify its presence through innovative marketing strategies and enhanced product offerings.

Financial Performance and the ATM Offering

Before concluding the ATM program, Safety Shot successfully sold 397,064 shares, generating approximately $481,256. This funding will bolster the company's growth initiatives, reinforcing its financial stability.

The Upcoming Acquisition Impact

The anticipated acquisition of Yerbaé Brands Corp. is expected to expand Safety Shot's product lineup significantly, especially in the thriving market for healthy beverages. Yerbaé specializes in functional drinks, which complements Safety Shot’s mission to provide diverse wellness solutions for consumers.

Commitment to Enhancing Shareholder Value

Safety Shot's resolution to terminate the ATM program aligns with its goal of enhancing shareholder equity. The leadership believes that this significant step will resonate positively with investors, fostering a stable share price and increased market trust.

Boon added, "We are profoundly focused on creating value for our shareholders. Our strategy is set, and we're excited about the journey ahead as we continue to report strong results and execute our growth plans effectively."

About Safety Shot, Inc.

Safety Shot, Inc. is revolutionizing the wellness market with its innovative product Sure Shot, recognized as the first patented supplement to lower blood alcohol levels. Sure Shot positively impacts energy levels and mood, and is available for purchase online at various platforms. The company is excited to introduce business-to-business sales in 2025, allowing wider distribution across relevant markets such as restaurants, bars, and retailers.

Investor inquiries can be directed to the following:

Phone: 561-244-7100
Email: investors@drinksafetyshot.com

Frequently Asked Questions

What decisions were made by Safety Shot, Inc. regarding the ATM program?

Safety Shot, Inc. announced the termination of its ATM equity offering program, signaling confidence in its financial position.

How will the termination of the ATM program benefit shareholders?

Eliminating the ATM program reduces potential equity dilution, enhancing the value and stability of shares for investors.

What partnerships has Safety Shot secured recently?

The company has announced major distribution partnerships with retailers including 7-Eleven, Casey's, and King Soopers.

What acquisition is Safety Shot pursuing?

Safety Shot is acquiring Yerbaé Brands Corp. to enhance its product offerings in the functional beverage market.

How can investors contact Safety Shot, Inc.?

Investors can reach out via phone or email to get inquiries addressed by the company’s investor relations team.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Gnosis Lab's Grand Re-Opening: A New Era for Diagnostics

Updated Category News Views 260

Gnosis Lab Grand Re-Opening Celebration Gnosis, a modern diagnostic laboratory previously known as Mountain View Medical Laboratory, is excited to announce its grand re-opening at its flagship location. This event signifies a crucial transition for the lab as it seeks to blend years of reliable community service with a fresh identity and enhanced capabilities. Commitment...

Continue Reading
New Propane Contract Boosts Titan NRG (TTNN) Growth

Updated Category Stocks Views 404

Titan NRG, Inc. Announces Major Propane Contract Secured Titan NRG, Inc. (OTC: TTNN) has a big contract for the 150,000 gallons of propane supply. Given to one of its subsidiaries, this contract represents a significant turning point for the business. Under this contract, propane will be delivered over the next year to a southern Arizona reservation. Crucially in securing...

Continue Reading
Bitcoin Price Decline: Impact of DOJ and Economic Conditions

Updated Category News Views 259

Bitcoin Price Experiences a Notable Decline Bitcoin has recently faced a serious downturn, falling to around $93,925 as fears surrounding U.S. interest rate changes and potential government sales of Bitcoin emerged. This has created a concerning environment for cryptocurrency investors, highlighting the volatility of digital assets. Market Sentiment and Economic Shifts...

Continue Reading
Cogitate and One Inc Team Up to Revolutionize Payments

Updated Category News Views 169

Cogitate Partners with One Inc to Transform Digital Payments -Customers Enjoy a Seamless Experience by Unifying All Payment Flows into One Comprehensive Platform- Cogitate, a provider of cloud-native core policy, billing, and claims applications for insurers, is excited to announce its partnership with One Inc, the leading digital payments network specifically for the...

Continue Reading
Alnylam Pharmaceuticals Achieves New Stock Milestone of $287.88

Updated Category News Views 74

Alnylam Pharmaceuticals Reaches Record Stock Price Alnylam Pharmaceuticals Inc. has recently made headlines after its stock price reached a remarkable all-time high of $287.88. This surge demonstrates a substantial increase in investor confidence, bolstered by an impressive 1-year change of 71.84% in the company's stock. Known for its groundbreaking work in RNA...

Continue Reading